For: | Evans RPT, Mourad MM, Fisher SG, Bramhall SR. Evolving management of metaplasia and dysplasia in Barrett's epithelium. World J Gastroenterol 2016; 22(47): 10316-10324 [PMID: 28058012 DOI: 10.3748/wjg.v22.i47.10316] |
---|---|
URL: | https://www.wjgnet.com/1948-5190/full/v22/i47/10316.htm |
Number | Citing Articles |
1 |
James Franklin, Janusz Jankowski. Recent advances in understanding and preventing oesophageal cancer. F1000Research 2020; 9: 276 doi: 10.12688/f1000research.21971.1
|
2 |
Jacqui E. Allen. Laryngopharyngeal and Gastroesophageal Reflux. 2020; : 125 doi: 10.1007/978-3-030-48890-1_14
|
3 |
Ross J. Porter, Graeme I. Murray, Daniel P. Brice, Russell D. Petty, Mairi H. McLean. Novel biomarkers for risk stratification of Barrett’s oesophagus associated neoplastic progression–epithelial HMGB1 expression and stromal lymphocytic phenotype. British Journal of Cancer 2020; 122(4): 545 doi: 10.1038/s41416-019-0685-1
|
4 |
Sijana H. Dzinic, Zaid Mahdi, M. Margarida Bernardo, Semir Vranic, Haya Beydoun, Nadine Nahra, Amra Alijagic, Deanna Harajli, Aaron Pang, Dan M. Saliganan, Abid M. Rahman, Faruk Skenderi, Berisa Hasanbegovic, Gregory Dyson, Rafic Beydoun, Shijie Sheng, Daotai Nie. Maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma/gastroesophageal junction adenocarcinoma. PLOS ONE 2019; 14(4): e0215089 doi: 10.1371/journal.pone.0215089
|